Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genetic Breast Cancer Trial: carboplatin versus docetaxel in BRCA1/2 metastatic breast cancer
ISRCTN43372330Phase 2Completed
- Sponsor
- University College London
- Start
- Jan 2005
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
01
Overview
Phase 2, randomised, open-label trial in breast cancer comparing Carboplatin with Docetaxel (2 arms). Primary endpoint: Safety and efficacy of carboplatin. Started Jan 2005; status: completed.
02
Drugs
carboplatindocetaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on ISRCTN43372330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN43372330.